QScreen AI Inc. (3QP)
XMUN 
Summary
3QP Chart
Predictmedix AI positions Smart Health Stations as alternative to animal testing in clinical trials
Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) has highlighted the potential of its Smart Health AI Stations amid the Food and Drug Administration (FDA)'s move to phase out mandatory animal testing in drug development. The company sees the regulatory shift as an opportunity to position its technology as a scalable and human-focused alternative for early-stage clinical evaluations.
Predictmedix AI hits scan milestone with Smart Health Stations
Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) announced that it has surpassed more than 500,000 scans through its Smart Health AI Stations, reflecting the growing use of its AI-powered screening tools in healthcare, corporate, and public settings. The technology is designed to identify signs of infectious diseases, mental health conditions, and impairment through non-invasive, automated scans.
Predictmedix AI finalizes private placement, advances Smart Health AI Stations
Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) announced that it has completed the third and final tranche of its non-brokered private placement, raising C$100,000 to support its market expansion efforts. The company issued 5 million units at $0.02 per unit, with each unit consisting of one common share and a warrant exercisable at $0.05 per share for 24 months.
QScreen AI Inc. (3QP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has QScreen AI Inc. ever had a stock split?
QScreen AI Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Sheldon Kales CEO | XMUN Exchange | CA7469601032 ISIN |
| CA Country | 3 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Predictmedix AI Inc. is a forefront artificial intelligence (AI) firm dedicated to the advancement of AI-powered technologies catering primarily to the general workplace health and safety and healthcare industries. The company navigates through these sectors with two principal segments: Workplace Health and Safety, and Healthcare. Originally named Predictmedix Inc., the organization underwent a rebranding to Predictmedix AI Inc. in July 2023, marking a new chapter in its mission to integrate advanced AI into critical health and safety applications. Headquartered in Toronto, Canada, Predictmedix AI Inc. stands as a beacon of innovation in leveraging AI for the betterment of global health standards and workplace safety protocols.
Products and Services
- Disease Symptom Screening Solutions:
- Impairment Detection Screening Scanners:
- Mental Health Screening Stations:
- Mobile Wellbeing - Telemedicine Remote Patient Monitoring Platform:
This offering from Predictmedix AI Inc. is designed to streamline the preliminary screening process for infectious diseases. Utilizing cutting-edge AI, it assesses individuals for symptoms indicative of a higher likelihood of testing positive for infectious conditions, thus recommending those individuals for further definitive testing, such as rapid COVID tests. This technology aims at enhancing the efficiency and safety of workplaces and public health environments by identifying potential health threats before they become widespread.
These advanced scanners are a pivotal component of the company’s Workplace Health and Safety segment. They employ AI algorithms to detect signs of impairment caused by various factors such as drugs, alcohol, or fatigue. The goal is to prevent accidents and ensure a safer working environment by proactively identifying individuals who may not be in the best condition to perform their duties safely.
Understanding the critical importance of mental well-being in the workplace and beyond, Predictmedix AI Inc. has developed screening stations aimed at identifying signs of mental health issues. This service allows for early intervention and support for individuals potentially experiencing mental health challenges, emphasizing the company’s dedication to comprehensive health and safety measures.
The Mobile Wellbeing platform represents Predictmedix AI Inc.’s foray into telemedicine, offering a remote patient monitoring solution that connects patients with healthcare providers regardless of location. This service not only facilitates ongoing management of chronic conditions but also enables real-time health monitoring, thereby extending the reach of healthcare services and ensuring continuous care.
